converting website visitors

ThePoultrySite.com - news, features, articles and disease information for the poultry industry

Gallimune Flu H5N9



Characteristics of Gallimune Flu H5N9
  • Proven, inactivated vaccine technology
  • Developed from a strain tested at independent laboratories in the USA and Australia
  • Complies with OIE guidelines
  • Developed in response to the Asian AI outbreaks
Gallimune Flu H5N9
    Gallimune Flu H5N9

    Features & Benefits of Gallimune Flu H5N9

    • Contains H5N9 strain of AI
    • The hemagglutinin type that is involved in the current Asian outbreak
    • An unusual neuraminidase type that differs from the field strains in the current Asian outbreak
    • Allows use of the neuraminidase based DIVA testing methodology
    • Uses a 0.2 ml dose in broilers and a 0.3 ml dose in pullets
    • Low volume dose for easier, more accurate vaccine administration
    • Made with a well pathogenic AI strain
    • As recommended in OIE guidelines
    • Safer than unregulated vaccines made from
      highly pathogenic or uncharacterized AI strains









    Contact | Privacy | Legal Notification © 2011 Merial

    GENERAL REMINDER:
    Usage instructions & withdrawal periods may vary by Country.
    Always follow label instructions and consult your veterinarian.

    This page contains information on veterinary pharmaceutical and biological products that are sold in several different countries and areas where they may be marketed under different trade names and pursuant to different regulatory approvals. Accordingly, ThePoultrySite and Merial gives no guarantee that the details presented are correct with respect to all locations.

    Advertisments and/or reference to commercial products or trade names within information provided by ThePoultrySite.com does not constitute an endorsement by ThePoultrySite.com and does not imply discrimination against any other similar products.

    Our Sponsors

    Partners


    Seasonal Picks

    Poultry Breeds and Management